Rybelsus® 14mg Semaglutide Tablets

Rybelsus® 14mg Semaglutide Tablets

Rybelsus® 14mg is an oral tablet containing semaglutide, a glucagon-like peptide-1 receptor agonist, commonly known as a GLP-1 receptor agonist. It is a prescription medicine intended for use only under the supervision of a licensed healthcare professional.

Product Information

Product Name: Rybelsus® 14mg Semaglutide Tablets
Japanese Name: リベルサス錠14mg
Chinese Name: Rybelsus® 14mg（Semaglutide）口服錠
Active Ingredient: Semaglutide
Strength: 14mg
Dosage Form: Oral tablet
Route of Administration: Oral
Drug Class: GLP-1 receptor agonist
Brand Owner: Novo Nordisk
Product Type: Prescription medicine
Use: Use only as directed by a licensed healthcare professional

What Is Rybelsus® 14mg?

Rybelsus® 14mg contains semaglutide in a once-daily oral tablet form. Semaglutide belongs to the GLP-1 receptor agonist class, which is associated with blood glucose regulation, insulin response, glucagon secretion, gastric emptying, and appetite-related signaling.

The 14mg strength is commonly used as a higher maintenance strength when prescribed by a healthcare professional. It should not be used as a starting dose unless specifically directed by a doctor.

Key Features

– Contains semaglutide 14mg
– Oral tablet format
– Once-daily administration as directed
– Belongs to GLP-1 receptor agonist class
– Non-injectable semaglutide option
– Commonly used as a higher maintenance strength
– Manufactured by Novo Nordisk
– Prescription-only medicine
– Should be used with medical monitoring and lifestyle guidance

About Semaglutide

Semaglutide is a GLP-1 receptor agonist. GLP-1 receptor agonists work by activating GLP-1 receptors involved in metabolic regulation.

Under healthcare professional guidance, semaglutide may help support:

– Blood glucose management
– Insulin secretion response when blood glucose is elevated
– Reduced glucagon release when appropriate
– Slower gastric emptying
– Appetite and satiety-related signaling
– Overall metabolic care as part of a treatment plan

The effect and suitability of semaglutide depend on each patient’s health condition, current medications, medical history, and doctor’s assessment.

Dose Strength Information

The 14mg strength is generally considered a higher maintenance dose. A healthcare professional may determine whether 14mg is appropriate based on treatment response, side effects, blood glucose results, digestive tolerance, other medications, and overall health condition.

Patients should not increase, decrease, or stop the dose without medical advice.

How to Take Rybelsus® 14mg

Use exactly as directed by your doctor or pharmacist.

General administration guidance may include:

– Take once daily by mouth.
– Take on an empty stomach after waking.
– Take with a small amount of plain water.
– Wait before eating, drinking, or taking other oral medicines.
– Do not split, crush, or chew the tablet.
– Follow your prescribed dosing schedule carefully.

Always follow the official prescription label and your healthcare provider’s instructions.

Who May Be Prescribed Rybelsus® 14mg?

Rybelsus® 14mg may be prescribed by a healthcare professional for suitable adult patients who need GLP-1 receptor agonist therapy as part of a medical treatment plan.

A doctor may assess:

– Medical history
– Blood sugar control
– Current treatment plan
– Tolerability to semaglutide
– Digestive system condition
– Kidney and liver function
– Pregnancy or breastfeeding status
– Risk of drug interactions
– Risk of hypoglycemia when used with insulin or sulfonylureas

This medicine is not suitable for everyone.

Important Safety Information

Before using Rybelsus® 14mg, tell your healthcare provider if you:

– Have a history of pancreatitis
– Have severe stomach or intestinal problems
– Have kidney disease
– Have liver disease
– Have diabetic retinopathy
– Are pregnant, planning pregnancy, or breastfeeding
– Are taking insulin or sulfonylurea medicines
– Have a history of thyroid tumors or endocrine disorders
– Have allergies to semaglutide or any ingredient in the tablet
– Are taking other prescription or non-prescription medicines

Possible Side Effects

Common side effects may include:

– Nausea
– Vomiting
– Diarrhea
– Constipation
– Abdominal discomfort
– Loss of appetite
– Indigestion
– Bloating
– Fatigue

Serious side effects may occur rarely and require medical attention.

Seek medical help immediately if you experience:

– Severe or persistent abdominal pain
– Severe vomiting or dehydration
– Signs of pancreatitis
– Allergic reaction
– Vision changes
– Symptoms of low blood sugar, especially when used with insulin or sulfonylurea
– Neck lump, difficulty swallowing, or persistent hoarseness

Storage

Store according to the product package and pharmacist instructions.

General storage recommendations:

– Keep in original packaging.
– Protect from moisture.
– Store at room temperature unless otherwise stated.
– Keep away from children and pets.
– Do not use after the expiry date.

Related Products and Categories

You may also view related strengths such as Rybelsus 3mg Semaglutide Tablets and Rybelsus 7mg Semaglutide Tablets, or browse our GLP-1 Medication and Prescription Medicine categories for more related product information.

Official Product Information

For official medicine information, please refer to Novo Nordisk product information or consult a licensed healthcare professional.

Important Notes

– Rybelsus® 14mg is a prescription medicine.
– Use only under doctor supervision.
– Do not share this medicine with others.
– Do not use for cosmetic weight loss without medical indication.
– Do not change dose without medical advice.
– It is not a substitute for diet, exercise, or diabetes care.
– Individual results and tolerability vary.

Disclaimer

This product page is for general product information only and does not replace professional medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.